SerpinB3-IgM complex was positive in 2 out of 17 (12%) patients with chronic hepatitis, in 10 out of 36 (28%) patients with cirrhosis and in 6 out of 26 (23%) patients with HCC. Here, CD40LG is linked to hepatocellular carcinoma.